COVID-19 UPDATE: Firm Operations Continue Uninterrupted. Free Virtual Consultations Available. Click Here.
ACCIDENT NEWS

3 Injured in Crash on Interstate 680 at Capital Avenue


Vehicle Hits Tree, Catches Fire in San Jose Accident

San Jose, CA (June 3, 2020) – Three people were injured in a multi-vehicle crash in San Jose. The accident occurred on the evening of June 3 on Interstate 680.

An Acura and several other vehicles collided on the northbound 680 Freeway, on the Capital Avenue on-ramp. A vehicle slammed into a tree and split in half. Another vehicle rolled over and caught fire. Emergency crews arrived to tend to three victims. Two suffered critical injuries, while the other suffered minor injuries. 

#San Jose

#95132


August 31, 2020

Motorcyclist Injured in Crash on Highway 17 Near Sugarloaf Road

Motorcycle, Big Rig Collide in Scotts Valley Accident...


March 11, 2020

Man Killed in Head-on Crash on Highway 129 Near Rogge Lane

2 Vehicles Collide in Fatal Watsonville Accident...


April 3, 2020

1 Injured in Crash on Highway 18 Near Richard Street

Semi Truck, Sedan Collide Head-on in Lucerne Valley Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


September 21, 2020

Lawsuit: ‘Tens Of Thousands’ Of Elmiron Patients At Risk For Vision Loss

A lawsuit filed on September 8 claims that “tens of thousands” of Elmiron patients were put at risk and hurt as a result of Janssen Pharmaceuticals’ conduct.


September 21, 2020

Lawsuit Claims Gilead Made ‘Unlawful’ Payment Over Truvada Competition

A lawsuit filed on Thursday claims that Gilead made an “unlawful” payment to Cipla in exchange for Cipla’s agreement to not compete against Truvada. The complaint states the payment “likely” came in the form of a license to produce Atripla, a license to produce Hepatitis C drugs in India or both.